Cyclo Therapeutics, Inc.

• Accepted (ET)
• Mar 268-K—
  Current report0001437749-25-009255 · 243.1 KB
  SEC(opens sec.gov)
• Mar 248-K—
  Current report0001437749-25-008971 · 187.7 KB
  SEC(opens sec.gov)
• Mar 68-K—
  Current report0001437749-25-006408 · 384.3 KB
  SEC(opens sec.gov)
• Feb 48-K—
  Current report0001437749-25-002723 · 433.4 KB
  SEC(opens sec.gov)
• Jan 138-K—
  Current report0001437749-25-000947 · 172.7 KB
  SEC(opens sec.gov)
• Jan 38-K—
  Current report0001437749-25-000188 · 372.6 KB
  SEC(opens sec.gov)
• Dec 238-K—
  Current report0001437749-24-038293 · 228.2 KB
  SEC(opens sec.gov)
• Dec 1810-K/A—
  Cyclo Therapeutics, Inc.0001437749-24-037835 · 7.6 MB
  SEC(opens sec.gov)
• Dec 58-K—
  Current report0001437749-24-036802 · 381.8 KB
  SEC(opens sec.gov)
• Nov 2610-K/A—
  Cyclo Therapeutics, Inc.0001437749-24-036271 · 8.7 MB
  SEC(opens sec.gov)

• ARMISTICE CAPITAL, LLC10% Owner
• Boyd Steven10% Owner
• CONKLING WILLIAMDirector
• Cross ShawnDirector
• Farnan Joseph J JrDirector
• Fine Joshua MChief Financial Officer
• FINE N SCOTTDirector, Chief Executive Officer
• Hrynkow Sharon HemondChief Scientific Officer
• Kjems Lise LundChief Medical Officer
• Kusmierz Katarzyna10% Owner

No tickers on record.

• business

  6714 NW 16TH STREET, SUITE B

  GAINESVILLE, FL, 32653

• mailing

  PO BOX 1180

  ALACHUA, FL, 32616-1180

• CTD HOLDINGS INC2019-09-30
• CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC2000-03-30